China Universal Asset Management Company’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Buy |
67,069
+1,303
| +2% | +$2.24K | 0.01% | 353 |
|
|
2025
Q1 | $219K | Buy |
65,766
+1,141
| +2% | +$3.8K | 0.02% | 307 |
|
|
2024
Q4 | $478K | Buy |
64,625
+6,249
| +11% | +$46.2K | 0.04% | 255 |
|
|
2024
Q3 | $548K | Buy |
58,376
+25,500
| +78% | +$239K | 0.06% | 204 |
|
|
2024
Q2 | $264K | Sell |
32,876
-20,832
| -39% | -$167K | 0.04% | 203 |
|
|
2024
Q1 | $796K | Buy |
53,708
+24,106
| +81% | +$357K | 0.1% | 143 |
|
|
2023
Q4 | $241K | Buy |
29,602
+23,246
| +366% | +$189K | 0.05% | 189 |
|
|
2023
Q3 | $28.9K | Buy |
6,356
+3,414
| +116% | +$15.5K | 0.01% | 270 |
|
|
2023
Q2 | $20.7K | Sell |
2,942
-96
| -3% | -$676 | 0.01% | 266 |
|
|
2023
Q1 | $18.6K | Buy |
3,038
+1,435
| +90% | +$8.77K | 0.01% | 226 |
|
|
2022
Q4 | $10.2K | Buy |
1,603
+125
| +8% | +$799 | ﹤0.01% | 225 |
|
|
2022
Q3 | $14K | Buy |
+1,478
| New | +$14K | 0.01% | 178 |
|